Thursday, 11 September 2025
  
Login

Australia's most trusted
source of pharma news

Thursday, 11 September 2025
Ascott 2
Ascott 2
Aussies take home APAC Awards

Australian innovation has taken centre stage at the Asia Pacific Cell & Gene Therapy Excellence Awards 2025, with two companies picking up gongs.

Game changer wins GSK grant
Cutting-edge approach to infectious disease combining AI and genetic sequencing takes out prestigious $150,000 prize
TODAY
Company rolls out 9000 job cuts
Transformation aims to simplify operations, speed decision-making and redirect resources to growing its flagship business
TODAY
Next
Next
Meet industry's highest paid KOLs
See the Top 10 clinicians receiving the highest payments from pharma as well as which companies forked out how much
10 September
Boss shares update after resigning
After an unexpected exit from Novartis last week, ex-Country Head Matt Zeller makes his first public comment via LinkedIn
9 September
Pharma spend on HCPs revealed
While overall outlay has dropped see which companies are forking out the most, according to new transparency reporting data
9 September
Why this pharma is a top employer
Australian HR Awards recognise the outstanding employee experiences provided by this company across a range of measures
9 September
PRIME
PRIME
Latest Jobs
Pharma exits 27 markets
600-plus jobs to go as the company transitions to a partnership model for commercialisation... but the Australian team is spared
TODAY
Takeda to awaken US$9B market
Company heads to global regulators with a first-in-class treatment for narcolepsy after outstanding Phase 3 trial results
TODAY
Judge opens door to $500M market
Court declines an interlocutory injunction, paving the way for Sandoz to launch its biosim in a $500M blockbuster market
10 September
Pfizer pushes back on Trump rant
Sets the record straight on claims by the US President that it has failed to release the scientific findings of its drugs
10 September
Who's flown out for a global gig?
See which executive has headed to company HQ along with other job moves and promotions across the Australian industry
10 September
Roche smashes green target early
After already meeting its target of 100 per cent renewable energy at all its Australian premises, the company is pushing even further
10 September
Gloves off in take-over battle
Accusations of misinformation and scare tactics are being hurled concerning the disputed $672 million sale of Mayne Pharma
9 September
Dept squeezes PBAC deadline
Companies may need to scramble to meet the new requirements with MA pushing back on the lack of consultation
9 September
Pharma gifts team a week off
Well-being initiative gives the team uninterrupted time off for rest, relaxation or simply catching up of life admin
8 September
Will adopting AI make PBAC faster?
Department of Health Secretary says yes, promising faster evaluations but no one's talking about delays due to pricing
8 September
HCPs rate pharma patient-centricity
One in three Australian doctors say pharma in 'not very' or 'not at all' patient centric, according to a new survey
8 September
PBAC to tackle weighty question
The November PBAC meeting agenda has been updated with the Committee to discuss how to fund obesity drugs on the PBS
8 September
Export only drugs flood ARTG
TGA greenlights a raft of export only meds sponsored by four separate companies with just one scheduled medicine approved
8 September Approvals Action
Wanted: Five Aussie Country Heads
Novartis appoints interim leader while seeking a permanent Aussie country head alongside four other companies without a leader
5 September
PiF Jobs
PiF Jobs
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.